Orient Hontai Capital logo

Orient Hontai Capital

Asia, Beijing, China, Beijing

Description

Orient Hontai Capital is a Chinese private equity firm.

Investor Profile

Orient Hontai Capital has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C rounds (top funding stages).
  • Majority of deals are located in United States, China.
  • Strong thematic focus on Biotechnology, Biopharma, Neuroscience.

Stage Focus

  • Series C (100%)

Country Focus

  • United States (50%)
  • China (50%)

Industry Focus

  • Biotechnology
  • Biopharma
  • Neuroscience
  • Health Care
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Orient Hontai Capital frequently co-invest with?

Johnson & Johnson Innovation – JJDC
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Johnson & Johnson Robotics and Digital Solutions
North America, New Jersey, United States, New Brunswick
Co-Investments: 1
KTB Network
Asia, Kyonggi-do, South Korea, Seongnam
Co-Investments: 2
Trinity Innovation Fund
Asia, Beijing, China, Beijing
Co-Investments: 1
Wuxi Venture Capital Group
Asia, Anhui, China, Wuxi
Co-Investments: 1
TI
Asia, Beijing, China, Beijing
Co-Investments: 1
WI Harper Group
North America, California, United States, San Francisco
Co-Investments: 1
Panacea Venture
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Panacea Venture
North America, Midland, Cayman Islands, Grand Cayman
Co-Investments: 1
CDIB Capital
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 2

What are some of recent deals done by Orient Hontai Capital?

XW Laboratories

Wuhan, Hubei, China

XW Laboratories develops a portfolio of internally discovered product candidates for the potential treatment of neurological disorders.

BiotechnologyHealth CarePharmaceutical
Series CSep 18, 2020
Amount Raised: $40,000,000
XWPharma

Redwood City, California, United States

XWPharma is a neuroscience biotech company that is researching new medicines for sleep, neuropsychiatric, and other neglected CNS illnesses.

BiopharmaBiotechnologyNeuroscience
Series CSep 17, 2020
Amount Raised: $40,000,000

Find More Investors Like Orient Hontai Capital

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Orient Hontai Capital | Pipeseed